• Executive Management Team


    Founder, Executive Chairman, Co-Inventor of LEAF-4L6715
    • Former Executive VIP of Development and Merrimack Pharmaceuticals
    • VP of Medicine Development Strategy at GSK
    • Research Fellow at Eli Lily
    • Involved in the development and registration of anticancer drugs ALIMTA®, GEMZAR® and EVISTA®
    • Sole inventor of U.S. Patent No. 7,772,209, which was seminal for the commercial success of Lilly’s ALIMTA® 
  • Dr. Victor Moyo, MD

    Hematology & Oncology

    Chief Medical Officer, OncoPep, Inc., Former EVP & CMO, L.E.A.F. Pharmaceuticals and LEAF4Life; VP of Clinical Investigations, Merrimack – Developed Onivyde ®, a new pancreatic cancer drug with over $1B in sales

  • Prof. Xavier Pivot, MD, PhD


    General Director of Strasbourg Institute of Cancer (ICANS), Strasbourg, France, Former Chairman of the Oncology Department at the Hospital University of Besançon, France

  • Dr. Tawanda Gumbo, MD

    Infectious Disease

    Founder & CEO, Praedicare Inc. ; Former Director, Center for Infectious Diseases Research and Experimental Therapeutics, Baylor University, Dallas, Texas, USA

  • Dr. Daniel Von Hoff, MD, FACP


    Physician in Chief, Distinguished Translational Research Division at Translational Genomics Research Institute (Tgen) in Phoenix, Arizona, USA

  • Michael Slater


    Former Senior Vice President, Global Regulatory Affairs and Quality Systems at LEAF4Life, Inc., L.E.A.F. Pharmaceuticals and Merrimack. Previously VP of Regulatory Affairs for Millenium and Biogen